Market Cap 960.05M
Revenue (ttm) 0.00
Net Income (ttm) -127.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,397,100
Avg Vol 977,670
Day's Range N/A - N/A
Shares Out 49.36M
Stochastic %K 98%
Beta 1.45
Analysts Strong Sell
Price Target $45.89

Company Profile

Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences,...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 312 3013
Address:
Building 23, Suite 105 221 Crescent Street, Waltham, United States
stayput
stayput Jun. 24 at 5:01 PM
$JBIO Average $12.57.. sitting pretty
0 · Reply
Irish_lass
Irish_lass Jun. 23 at 2:29 PM
$JBIO Thanks XBI
0 · Reply
Irish_lass
Irish_lass Jun. 22 at 6:49 PM
$JBIO Swing for the fences
0 · Reply
Irish_lass
Irish_lass Jun. 22 at 3:19 PM
$JBIO 👀
0 · Reply
outlawinvestor1
outlawinvestor1 Jun. 19 at 9:59 PM
$APGE 💥🥳 $SYRE $ORKA $JBIO $CBIO https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-nears-11-billion-deal-apogee-therapeutics-ft-reports-2026-06-19/
0 · Reply
Quantumup
Quantumup Jun. 15 at 12:47 PM
UBS🏁 $JBIO Buy; $45 and said: We believe JBIO's lead program JADE101 could be a best-in-class drug in the $20B+ IgAN market and could have $3-4B in peak sales potential. $VERA $TVTX NVS VRTX IONS AZN Here's what UBS went on to say: https://x.com/Quantumup1/status/2066502213355135474?s=20
0 · Reply
SuperGreenToday
SuperGreenToday Jun. 12 at 10:17 AM
$JBIO Share Price: $16.06 Contract Selected: Nov 20, 2026 $20 Calls Buy Zone: $3.53 – $4.37 Target Zone: $6.24 – $7.63 Potential Upside: 67% ROI Time to Expiration: 160 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
focafoca99
focafoca99 Jun. 11 at 8:38 PM
$JBIO modified its Articles of Incorporation to waive jury trials, effective June 10, 2026.
0 · Reply
focafoca99
focafoca99 Jun. 4 at 9:14 PM
$JBIO offered a $15 per share public offering of 10 million shares, targeting about $140 million in net proceeds.
0 · Reply
MarketBeat
MarketBeat Jun. 2 at 1:09 AM
https://marketbeat.com/a/8686852/ $JBIO Jade Biosciences’ JADE101 Delivers Deep IgA Cuts, Clearing Path for Kidney Trials
0 · Reply
Latest News on JBIO
Jade Biosciences initiated with a Buy at UBS

2026-06-15T09:35:19.000Z - 9 days ago

Jade Biosciences initiated with a Buy at UBS


Jade Biosciences Proxy statement: Proxy filing

Jun 5, 2026, 8:00 AM EDT - 19 days ago

Jade Biosciences Proxy statement: Proxy filing


Jade Biosciences 10M share Secondary priced at $15.00

2026-06-04T10:37:33.000Z - 20 days ago

Jade Biosciences 10M share Secondary priced at $15.00


Jade Biosciences announces interim results from JADE101 trial

2026-06-01T12:08:46.000Z - 23 days ago

Jade Biosciences announces interim results from JADE101 trial


Jade Biosciences Transcript: Study update

Jun 1, 2026, 8:00 AM EDT - 23 days ago

Jade Biosciences Transcript: Study update


Jade Biosciences Slides: Study update

Jun 1, 2026, 8:00 AM EDT - 23 days ago

Jade Biosciences Slides: Study update


Jade Biosciences Press release: Study update

Jun 1, 2026, 8:00 AM EDT - 23 days ago

Jade Biosciences Press release: Study update


Jade Biosciences Slides: Company presentation

Jun 1, 2026, 7:00 AM EDT - 23 days ago

Jade Biosciences Slides: Company presentation


Jade Biosciences files $600M mixed securities shelf

2026-05-07T22:32:12.000Z - 6 weeks ago

Jade Biosciences files $600M mixed securities shelf


Jade Biosciences Registration statement: Registration filing

May 7, 2026, 8:00 AM EDT - 6 weeks ago

Jade Biosciences Registration statement: Registration filing


Jade Biosciences Registration statement: Registration filing

May 7, 2026, 8:00 AM EDT - 6 weeks ago

Jade Biosciences Registration statement: Registration filing


Jade Biosciences Quarterly report: Q1 2026

May 7, 2026, 7:00 AM EDT - 6 weeks ago

Jade Biosciences Quarterly report: Q1 2026


Jade Biosciences Earnings release: Q1 2026

May 7, 2026, 7:00 AM EDT - 6 weeks ago

Jade Biosciences Earnings release: Q1 2026


Jade Biosciences Slides: Company presentation

May 7, 2026, 7:00 AM EDT - 6 weeks ago

Jade Biosciences Slides: Company presentation


Jade Biosciences Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 2 months ago

Jade Biosciences Proxy statement: Proxy filing


Jade Biosciences Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 2 months ago

Jade Biosciences Proxy statement: Proxy filing


Jade Biosciences Appoints Edward R. Conner, M.D.

Apr 22, 2026, 7:00 AM EDT - 2 months ago

Jade Biosciences Appoints Edward R. Conner, M.D.


Jade Biosciences Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 2 months ago

Jade Biosciences Proxy statement: Proxy filing


Jade Biosciences price target raised to $39 from $28 at BTIG

2026-03-16T11:57:55.000Z - 3 months ago

Jade Biosciences price target raised to $39 from $28 at BTIG


Jade Biosciences Annual report: Q4 2025

Mar 6, 2026, 7:00 AM EST - 3 months ago

Jade Biosciences Annual report: Q4 2025


Jade Biosciences Earnings release: Q4 2025

Mar 6, 2026, 7:00 AM EST - 3 months ago

Jade Biosciences Earnings release: Q4 2025


Jade Biosciences Slides: Corporate presentation

Mar 5, 2026, 7:00 AM EST - 3 months ago

Jade Biosciences Slides: Corporate presentation


Jade Biosciences to Participate in Upcoming Conferences

Feb 11, 2026, 7:00 AM EST - 4 months ago

Jade Biosciences to Participate in Upcoming Conferences


Jade Biosciences Slides: Corporate presentation

Jan 2, 2026, 7:00 AM EST - 6 months ago

Jade Biosciences Slides: Corporate presentation


Jade Biosciences Registration statement: Registration Filing

Dec 22, 2025, 7:00 AM EST - 6 months ago

Jade Biosciences Registration statement: Registration Filing


Jade Biosciences Announces $45 Million Private Placement

Dec 15, 2025, 7:00 AM EST - 6 months ago

Jade Biosciences Announces $45 Million Private Placement


Jade Biosciences Quarterly report: Q3 2025

Nov 14, 2025, 7:00 AM EST - 7 months ago

Jade Biosciences Quarterly report: Q3 2025


Jade Biosciences Earnings release: Q3 2025

Nov 14, 2025, 7:00 AM EST - 7 months ago

Jade Biosciences Earnings release: Q3 2025


Jade Biosciences Slides: Corporate Presentation

Nov 13, 2025, 6:00 PM EST - 7 months ago

Jade Biosciences Slides: Corporate Presentation


Jade Biosciences Slides: Corporate Presentation

Nov 12, 2025, 6:00 PM EST - 8 months ago

Jade Biosciences Slides: Corporate Presentation


Jade Biosciences Transcript: Stifel 2025 Healthcare Conference

Nov 12, 2025, 4:00 PM EST - 8 months ago

Jade Biosciences Transcript: Stifel 2025 Healthcare Conference


Jade Biosciences Transcript: Investor Update

Oct 7, 2025, 8:00 AM EDT - 9 months ago

Jade Biosciences Transcript: Investor Update


Jade Biosciences Press release: Investor Update

Oct 7, 2025, 8:00 AM EDT - 9 months ago

Jade Biosciences Press release: Investor Update


Jade Biosciences Slides: Investor Update

Oct 7, 2025, 8:00 AM EDT - 9 months ago

Jade Biosciences Slides: Investor Update


Jade Biosciences Announces $135 Million Private Placement

Oct 7, 2025, 7:00 AM EDT - 9 months ago

Jade Biosciences Announces $135 Million Private Placement


Jade Biosciences Slides: Corporate Presentation

Aug 29, 2025, 12:00 PM EDT - 10 months ago

Jade Biosciences Slides: Corporate Presentation


Jade Biosciences Quarterly report: Q2 2025

Aug 13, 2025, 7:00 AM EDT - 11 months ago

Jade Biosciences Quarterly report: Q2 2025


Jade Biosciences Earnings release: Q2 2025

Aug 13, 2025, 7:00 AM EDT - 11 months ago

Jade Biosciences Earnings release: Q2 2025


Jade Biosciences Transcript: ERA 2025 Conference

Jun 9, 2025, 8:00 AM EDT - 1 year ago

Jade Biosciences Transcript: ERA 2025 Conference


Jade Biosciences Slides: FY 2025

Jun 9, 2025, 8:00 AM EDT - 1 year ago

Jade Biosciences Slides: FY 2025


Jade Biosciences Slides: Corporate Presentation

Jun 8, 2025, 6:00 PM EDT - 1 year ago

Jade Biosciences Slides: Corporate Presentation


Jade Biosciences Transcript: Jefferies Healthcare Conference

Jun 4, 2025, 12:25 PM EDT - 1 year ago

Jade Biosciences Transcript: Jefferies Healthcare Conference


Jade Biosciences Quarterly report: Q1 2025

May 13, 2025, 6:00 PM EDT - 1 year ago

Jade Biosciences Quarterly report: Q1 2025


Jade Biosciences Earnings release: Q1 2025

May 13, 2025, 6:00 PM EDT - 1 year ago

Jade Biosciences Earnings release: Q1 2025


stayput
stayput Jun. 24 at 5:01 PM
$JBIO Average $12.57.. sitting pretty
0 · Reply
Irish_lass
Irish_lass Jun. 23 at 2:29 PM
$JBIO Thanks XBI
0 · Reply
Irish_lass
Irish_lass Jun. 22 at 6:49 PM
$JBIO Swing for the fences
0 · Reply
Irish_lass
Irish_lass Jun. 22 at 3:19 PM
$JBIO 👀
0 · Reply
outlawinvestor1
outlawinvestor1 Jun. 19 at 9:59 PM
$APGE 💥🥳 $SYRE $ORKA $JBIO $CBIO https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-nears-11-billion-deal-apogee-therapeutics-ft-reports-2026-06-19/
0 · Reply
Quantumup
Quantumup Jun. 15 at 12:47 PM
UBS🏁 $JBIO Buy; $45 and said: We believe JBIO's lead program JADE101 could be a best-in-class drug in the $20B+ IgAN market and could have $3-4B in peak sales potential. $VERA $TVTX NVS VRTX IONS AZN Here's what UBS went on to say: https://x.com/Quantumup1/status/2066502213355135474?s=20
0 · Reply
SuperGreenToday
SuperGreenToday Jun. 12 at 10:17 AM
$JBIO Share Price: $16.06 Contract Selected: Nov 20, 2026 $20 Calls Buy Zone: $3.53 – $4.37 Target Zone: $6.24 – $7.63 Potential Upside: 67% ROI Time to Expiration: 160 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
focafoca99
focafoca99 Jun. 11 at 8:38 PM
$JBIO modified its Articles of Incorporation to waive jury trials, effective June 10, 2026.
0 · Reply
focafoca99
focafoca99 Jun. 4 at 9:14 PM
$JBIO offered a $15 per share public offering of 10 million shares, targeting about $140 million in net proceeds.
0 · Reply
MarketBeat
MarketBeat Jun. 2 at 1:09 AM
https://marketbeat.com/a/8686852/ $JBIO Jade Biosciences’ JADE101 Delivers Deep IgA Cuts, Clearing Path for Kidney Trials
0 · Reply
focafoca99
focafoca99 Jun. 1 at 12:08 PM
$JBIO shows interim Phase 1 data with about 70% IgA reduction from JADE101 in healthy volunteers.
0 · Reply
Pagal22
Pagal22 May. 30 at 4:13 PM
0 · Reply
Pagal22
Pagal22 May. 30 at 4:13 PM
0 · Reply
Icarus81
Icarus81 May. 29 at 8:54 PM
$JBIO your shorts are going to burn
1 · Reply
Monkey7779192
Monkey7779192 May. 29 at 8:51 PM
$JBIO Looking at open on Monday for potential trade.
0 · Reply
Monkey7779192
Monkey7779192 May. 29 at 8:50 PM
$JBIO Looks like a good short opportunity on Monday open.
0 · Reply
Merlintrader
Merlintrader May. 26 at 4:40 PM
$JBIO Biotech Catalyst Watch: Phase 2 IgAN Start, CRB-701 Cancer Data And Cullinan Autoimmune Updates $JBIO $CRBP $CGEM https://www.merlintrader.com/biotech-catalyst-jun2026b/
0 · Reply
outlawinvestor1
outlawinvestor1 May. 16 at 10:04 AM
updated paragon family of extended life biologics. https://www.paragontherapeutics.com/ $APGE $SYRE $ORKA $JBIO $CBIO
1 · Reply
BreakoutsHappen
BreakoutsHappen Apr. 15 at 2:16 PM
$JBIO is one of the few names actually working today, pushing higher while most of the tape is flat to red. The move looks flow-driven more than anything else, with volume picking up as the stock grinds higher. These are the types of setups traders tend to focus on intraday — not necessarily because of a major catalyst, but because money is clearly rotating into the name. Biotech continues to be one of the few pockets where you can still get clean moves, and JBIO is a good example of that today. As long as it holds up and doesn’t give back gains too quickly, it stays on the radar. That said, these moves can fade fast. If momentum stalls or volume drops off, it can unwind just as quickly as it went up.
0 · Reply
focafoca99
focafoca99 Apr. 3 at 8:30 PM
$JBIO approved a 2026 inducement equity plan for future new-hire awards.
0 · Reply
kshonstocks
kshonstocks Apr. 1 at 3:31 PM
good early volume $JBIO
1 · Reply